4//SEC Filing
Tenenbaum Fabian 4
Accession 0001600132-19-000131
CIK 0001600132other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:52 PM ET
Size
5.3 KB
Accession
0001600132-19-000131
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-26+1,752,000→ 5,440,697 totalExercise: $0.50Exp: 2029-09-26→ Common Stock (1,752,000 underlying)
Footnotes (1)
- [F1]1. This option was granted on September 26, 2019. This option vests in quarterly installments over a four-years period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001641300
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:52 PM ET
- Size
- 5.3 KB